[Migalastat (Fabry disease) – Addendum to Commission A23-88]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

Record ID 32018011240

German

Original Title: Migalastat (Morbus Fabry)

Details

Project Status: Completed

URL for project: https://www.iqwig.de/projekte/a24-10.html

Year Published: 2024

URL for published report: https://www.iqwig.de/download/a24-10_migalastat_addendum-zum-projekt-a23-88_v1-0.pdf

English language abstract: There is no English language summary available

Publication Type: Full HTA

Country: Germany

DOI: https://doi.org/10.60584/A24-10

MeSH Terms

Fabry Disease
Enzyme Replacement Therapy
1-Deoxynojirimycin
alpha-Galactosidase
Adolescent
Adult

Keywords

Migalastat
Fabry Disease
Adolescent
Adult
Benefit Assessment
NCT01218659

Contact

Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)

Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851

Contact Email: berichte@iqwig.de

Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.